Research & Innovation News



Dal News

Wednesday, March 13, 2024
Canadian battery science is about to get a turbocharge with the creation of the country’s first university-based battery prototyping and testing facility — a game-changer that will also be a magnet for industry in urgent need of the sophisticated equipment and the expertise to operate it.
Tuesday, March 19, 2024
The fellowship will support Dr. Elaine Craig in her study aimed at understanding why so many sexual assault cases fail to progress to trial and how we can improve the investigation and prosecution of these offences.
Wednesday, March 13, 2024
The new investments made through federal research grant programs will help Dalhousie researchers deliver tangible solutions to challenges faced by Nova Scotians and people across Canada.
Tuesday, February 27, 2024
A new lab established at Dalhousie this week has partnered with a local energy provider to explore applications of green hydrogen that could assist Nova Scotia in its efforts to achieve net-zero greenhouse gas emissions by 2050.
Monday, April 1, 2024
New research confirms that COVID-19 vaccines are safe and effective at reducing the cardiovascular complications that are a hallmark of COVID-19 infection.


The Conversation Canada

Dalhousie University is proud to have signed on as a founding partner of The Conversation Canada, a new-to-Canada media outlet providing independent, high-quality explanatory journalism.

This is the sixth affiliate of The Conversation, a global network. The format includes relevant and informed articles, which are written by researchers and academics in their areas of expertise and edited by experienced journalists

Interested in becoming an author?
Dalhousie academics and researchers, including graduate students, who would like to promote their research through The Conversation can simply register as an author and pitch a story idea

Articles written by Dalhousie researchers

Dalhousie Contact:
Andrew Riley,
Communications Manager, Office of the Vice President Research and Innovation
Cell: (902) 456-7904